Table 2 Preoperative finding in patients who undergoing robot-assisted laparoscopic prostatectomy
Preoperative factor | Whole study cohort |
|---|---|
| Â | n = 58 |
Age (years) | 69 (62 - 73) |
Body mass index (kg.m-2) | 25.4 (23.1 - 26.4) |
Comorbidity | |
 Diabetes mellitus | 18 (31.0%) |
 Hypertension | 20 (34.5%) |
Current smoker | 29 (50.0%) |
Prostate cancer stage | |
 Stage 1 | 23 (39.7%) |
 Stage 2 | 28 (48.3%) |
 Stage 3 | 7 (12.1%) |
Laboratory finding | |
 Prostate specific antigen (ng.mL-1) | 8.5 (5.3 - 19.4) |
 WBC count (x 109.L-1) | 6.2 (5.5 - 7.4) |
  Neutrophil (%) | 57.9 (51.6 - 66.6) |
  Lymphocyte (%) | 29.7 (25.4 - 37.7) |
 Hematocrit (%) | 42.9 (40.5 - 44.8) |
  MCV (fL) | 91.1 (89.3 - 93.4) |
  MCH (pg) | 31.4 (30.5 - 32.4) |
  MCHC (%) | 34.1 (33.3 - 34.8) |
 Glucose (mg.dL-1) | 106.0 (94.0 - 113.0) |
 Blood urea nitrogen (mg.dL-1) | 15.9 (14.4 - 19.5) |
 Creatinine (mg.dL-1) | 0.9 (0.8 - 1.1) |
 Total Protein (g.dL-1) | 7.0 (6.7 - 7.3) |
 Albumin (g.dL-1) | 4.4 (4.2 - 4.6) |
 Sodium (mEq.L-1) | 142 (140 - 144) |
 Potassium (mEq.L-1) | 4.5 (4.3 - 4.8) |
 Platelet count ( x 109.L-1) | 205.0 (178.5 - 224.3) |
 International normalized ratio | 1.1 (1.0 - 1.1) |
 Activated PTT (sec) | 26.6 (25.2 - 27.6) |
 Fibrinogen (mg.dL-1) | 254 (221 - 290) |
 Total cholesterol (mg.dL-1) | 176 (155 - 198) |
 Triglyceride (mg.dL-1) | 88 (67 - 149) |
 HDL-Cholesterol (mg.dL-1) | 50 (42 - 55) |
 LDL-Cholesterol (mg.dL-1) | 93 (74 - 120) |